Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Review

Emerging treatments in type 2 diabetes: focus on canagliflozin

       
Total article views   HTML views PDF downloads Totals
11,414 Dovepress* 9,267+ 2,393 11,660
PubMed Central* 2,147 966 3,113
Totals 11,414 3,359 14,773
*Since 21 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar